Outcome of HIV-1-associated cryptococcal meningitis, Denmark 19882008

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 3, 2012, Pages 197-200

  Mathiesen, Inger Hee Mabuza ^a   Knudsen, Jenny Dahl ^a   Gerstoft, Jan ^b   Cowan, Susan ^c   Benfield, Thomas ^a,d  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cryptococcus neoformans; Denmark; HIV; Meningitis

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; CRYPTOCOCCAL MENINGITIS; DEATH; DENMARK; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MENTAL HEALTH; MORTALITY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIFUNGAL AGENTS; DENMARK; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84857513194     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.611168     Document Type: Article

References (13)

1. Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS 2007;21:2119-29. (Pubitemid 350287209)
2. Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F. Incidence and risk factors of immune reconstitution infl ammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005;19:1043-9. (Pubitemid 40961144)
3. Antinori S, Ridolfo A, Fasan M, Magni C, Galimberti L, Milazzo L, et al. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy. HIV Med 2009;10:6-11.
4. Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 2007; 4:e21.
5. Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O. Major role for amphotericin B-fl ucytosine combination in severe cryptococcosis. PLoS One 2008;3:e2870.
6. Knudsen JD, Jensen L, Sorensen TL, Jensen T, Kjersem H, Stenderup J, et al. Cryptococcosis in Denmark: an analysis of 28 cases in 1988-1993. Scand J Infect Dis 1997;29: 51-5.
7. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: the Danish HIV cohort study. Int J Epidemiol 2009;38:1202-6.
8. Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006;20:2183-91. (Pubitemid 44684709)
9. Kambugu A, Meya DB, Rhein J, O'Brien M, Janoff EN, Ronald AR, et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008;46: 1694-701. (Pubitemid 351706766)
10. Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009;4:e5575.
11. Bicanic T, Meintjes G, Rebe K, Williams A, Loyse A, Wood R, et al. Immune reconstitution infl ammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009;51:130-4.
12. Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, Lederman MM, et al. Risk factor analyses for immune reconstitution infl ammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One 2010;5:e11416.
13. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, et al. Comparison of amphotericin B with fl uconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992; 326:83-9.